Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

149.80 +1.65 (+1.11%)

Streaming Delayed Price Updated: 1:34 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2 3 4 5 6 7 8 9

...

42 43 Next >

Janux Stock Is Rising Pre-Market After A New Oncology Deal With Bristol Myers Squibb ↗

January 22, 2026

Via Stocktwits

Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗

January 16, 2026

ARK doubles down on a CRISPR bet as Intellia Therapeutics’ stock heads for its best week since October.

Via Stocktwits

Topics Artificial Intelligence ETFs

Nano-Cap Regentis Biomaterials Stock Is Up Nearly 15% This Year: Why Retail Traders Are Swarming It ↗

January 16, 2026

Heading to close this week as its best week since IPO, RGNT has become a retail favorite with surging followers on Stocktwits.

Via Stocktwits

Topics Initial Public Offering Intellectual Property

MLTX Stock Erases Most Of 2025 Loses As Wall Street, Retail Bets On FDA Feedback For Sonelokimab ↗

January 15, 2026

The FDA said that the drug, which treats a chronic inflammatory skin disorder, could establish evidence without additional trials.

Via Stocktwits

TG Therapeutics Stock Pops As Briumvi Boom Reignites Bull Case: Goldman Sachs Sees Room For 32% Rally ↗

January 15, 2026

Via Stocktwits

BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? ↗

January 12, 2026

Via Stocktwits

Is Molina Healthcare The Next GEICO? Michael Burry Feels It's A ‘Special One’ ↗

December 31, 2025

Via Stocktwits

Retail Traders Are Piling Into TG Therapeutics – What’s Driving The Chatter? ↗

January 14, 2026

On Tuesday, the company provided the revenue outlook for 2026 and fourth-quarter (Q4) and fiscal year 2025 revenue projection for BRIUMVI.

Via Stocktwits

Topics Artificial Intelligence

Ventyx’s $1.2B Buyout By Eli Lilly Proves Timing Often Beats Conviction In Biotech Investing — A VC Explains ↗

January 07, 2026

Bottom buyers saw over 2,000% gains, while IPO investors merely broke even after a 90% drawdown, according to Atlas Venture’s Bruce Booth.

Via Stocktwits

Topics Initial Public Offering

The Great Rebalancing: Why Healthcare is Leading the Market Charge in 2026

January 06, 2026

As the first week of 2026 draws to a close, a distinct shift in market leadership has become the defining story for Wall Street. After a multi-year period where technology and artificial intelligence...

Via MarketMinute

Topics Artificial Intelligence Economy Government

The Great Rebalancing: Tech Giants Retreat as Investors Pivot to Defensive Safety in 2025's Final Days

December 29, 2025

As the curtain closes on 2025, the "Great Rebalancing" has taken center stage in the financial markets. On this December 29, 2025, the dominant narrative that fueled triple-digit gains for AI-centric...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

Sector Rotation: 2 Smart Money Moves for 2026 ↗

December 26, 2025

Via MarketBeat

Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗

December 24, 2025

This basket of 64 medical device stocks could raise its dividend for decades.

Via The Motley Fool

Topics ETFs Government Supply Chain

S&P 500 Stumbles as Mixed Jobs Report Fuels Fed Speculation, Ford Axes F-150 Lightning in Major EV Pivot

December 16, 2025

The U.S. stock market experienced a notable downturn on Tuesday, December 16, 2025, with the S&P 500 leading the retreat, following the release of a November jobs report that presented a complex and...

Via MarketMinute

Topics Economy Electric Vehicles Energy

The Top 3 Investment Themes That Will Dominate 2026 ↗

December 10, 2025

Via MarketBeat

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

December 01, 2025

Via MarketBeat

Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗

November 20, 2025

Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.

Via Benzinga

Interest Rate Hikes: A Looming Threat or Hidden Opportunity for the Stock Market?

November 19, 2025

As of mid-November 2025, the financial markets are grappling with a pervasive sense of uncertainty, primarily driven by the persistent specter of elevated interest rates. The "higher for longer"...

Via MarketMinute

Topics Economy Stocks

Tech Edges Up Ahead Of Nvidia's Earnings, Bitcoin Sinks Below $90,000: What's Moving Markets Wednesday? ↗

November 19, 2025

All eyes are on Nvidia Corp. (NASDAQ:NVDA) as the world's most valuable company prepares to report third-quarter earnings after the close, a pivotal moment that could steer

Via Benzinga

Leading And Lagging Sectors For November 19, 2025 ↗

November 19, 2025

Via Benzinga

Bank of America Flashes "Sell Signal" as Investor Cash Dries Up, Raising Market Stability Concerns

November 18, 2025

Bank of America (NYSE: BAC) has recently sounded a significant alarm for the stock market, issuing a "sell signal" that has sent ripples of concern through the financial world. This cautionary...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Tech Stocks Drop, Pharma Gains As Sector Rotation Picks Up: What's Moving Markets Tuesday? ↗

November 18, 2025

Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New York, extending its month-to-date slide to more than 5%.

Via Benzinga

Leading And Lagging Sectors For November 18, 2025 ↗

November 18, 2025

Via Benzinga

Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring ↗

November 17, 2025

AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.

Via Benzinga

Topics Artificial Intelligence

Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗

November 17, 2025

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.

Via Benzinga

Topics ETFs

Alphabet Rallies To Record Highs, Bitcoin Falters At $94,000: What's Moving Markets Monday? ↗

November 17, 2025

Wall Street kicked off the new week on a flat note after the worst weekly slump for tech stocks since April, as investors remained cautious ahead of a flood of economic data following the end of the...

Via Benzinga

Leading And Lagging Sectors For November 17, 2025 ↗

November 17, 2025

Via Benzinga

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗

November 17, 2025

Healthcare stocks have far outperformed the broader market over the past month.

Via The Motley Fool

Topics ETFs Government World Trade

Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗

November 15, 2025

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize.

Via Benzinga

Topics ETFs

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.